United States Breast Pumps Market Outlook to 2030: Size, Share, Growth and Trends

The United States Breast Pumps Market is sized at USD 1,390 Mn in 2024, which is the locked base year for this report. On a first-sale revenue basis, the market also moved 9.8 Mn units in 2024, indicating that category scale is already material for both consumer health platforms and clinical device suppliers. The definition used here includes manufacturer and distributor revenue across retail, online, and hospital or institutional channels, but excludes separately sold accessories and consumables. That lens is important because it captures the monetized device market rather than broader lactation spending.

The base-case outlook projects the United States Breast Pumps Market at USD 2,366 Mn by 2030, implying a 2025-2030 CAGR of 9.3%. This is a faster trajectory than the estimated 6.0% CAGR recorded over 2019-2024. The acceleration is driven less by demographic expansion and more by premium mix, higher wearable penetration, improved hospital-to-home conversion, and stronger payer or DME routing. In other words, future value growth is expected to come from better monetization per user and better product mix rather than a materially larger annual birth cohort.

Profit pools are shifting toward premium electric formats, especially wearable and connected devices, while manual formats become increasingly marginal. In 2024, the largest revenue pool was Double Electric Breast Pumps (Non-Wearable) at USD 445 Mn, while Smart / App-Connected Breast Pumps are the fastest-growing segment at 18.5% CAGR. The top three revenue pools already account for 71.9% of 2024 market value, showing that category economics are concentrated in high-utility, higher-ASP products. For management teams, this means margin strategy should focus on premium conversion, not on broad low-price volume capture.

The strongest structural demand driver is the combination of a large annual birth base and continued breastfeeding participation, reinforced by reimbursement and workplace pumping needs. The United States recorded 3,622,673 live births in 2024, and 85.7% of infants born in 2022 were ever breastfed. That creates a large potential user funnel. Demand is then sustained by return-to-work behavior, because mothers of children under age one posted a 61.9% labor-force participation rate in 2024. Together, these factors make pumping a functional maternal health device need rather than a niche optional purchase.

The largest structural constraint is that birth volume is no longer a reliable long-term expansion engine. The U.S. total fertility rate was 1,626.5 births per 1,000 women in 2024, well below the replacement threshold of 2,100. That means the market cannot depend on organic cohort expansion and must instead create value through mix upgrade, reimbursement capture, and premium features. A second constraint is fragmentation in benefit design, because plans can still influence manual versus electric eligibility, rental terms, and timing, which can compress realized premium conversion even when coverage is broadly available.

The United States is the largest market among a selected developed peer set that includes Canada, the United Kingdom, Germany, France, and Australia. The U.S. base is materially larger because it combines a much bigger birth cohort with reimbursement-backed access and strong direct-to-consumer plus DME channel depth. On this basis, the United States Breast Pumps Market ranks 1st in the peer set with USD 1,390 Mn in 2024 and outgrows the peer average through a 9.3% CAGR in 2025-2030. Relative scale and growth both support the U.S. as the core developed-market capital allocation priority.